Drug Discovery startups in San Francisco Bay Area

Tamarind Bio

San Francisco

Tamarind provides access to AI-powered drug discovery for scientists, used by thousands from pharma, biotech, and academia, serving a broad, cross-industry research community.

Inductive Bio

San Francisco

Inductive Bio uses data, machine learning, software, and domain expertise to rapidly solve ADMET problems with speed and precision, streamlining ADMET workflows as a focused provider in the ADMET problem space.

General Proximity

San Francisco

**General Proximity** The next generation of induced-proximity medicines. Active biotech drug-discovery San Francisco **Founders** Armand Cognetta Founder Armand completed his PhD in Chemical Biology at the Scripps Research Institute un

Bindwell

San Francisco

Bindwell uses AI to discover new pesticides, replacing slow lab work and accelerating discovery by 100×. The company is a small team of Caltech and Wolfram Research alumni with drug-discovery ML experience, aiming to rebuild agrochemical R&

Diffuse Bio

San Carlos

Diffuse builds generative AI for protein design, with coverage from The New York Times and NBC News; it has produced the first crystal structures of AI-designed proteins and diffusion models for structure and sequence generation.

Verge Genomics

San Francisco

Verge Genomics uses AI and human tissue data in its CONVERGE platform to map disease biology, identify targets, and de-risk drug development, with two drugs in clinical trials, 282 targets discovered, and partnerships worth $1.6B.